(Q37039021)

17 August 2017

1 reference

title

Liposomal nanomedicines (English)

1 reference

17 August 2017

1 reference

2

Pieter R Cullis

1 reference

17 August 2017

David B Fenske

1

1 reference

PubMed ID

18095927

17 August 2017

language of work or name

English

0 references

publication date

1 January 2008

1 reference

Expert Opinion on Drug Delivery

17 August 2017

1 reference

17 August 2017

5

1 reference

17 August 2017

1

1 reference

17 August 2017

25-44

1 reference

Drug delivery systems: entering the mainstream

17 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.25

The liposomal formulation of doxorubicin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.25

Entrapment of small molecules and nucleic acid-based drugs in liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.25

Highly immunostimulatory CpG-free oligodeoxynucleotides for activation of human leukocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.25

Encapsulation in liposomal nanoparticles enhances the immunostimulatory, adjuvant and anti-tumor activity of subcutaneously administered CpG ODN.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.25

RNAi-mediated gene silencing in non-human primates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.25

Potentiality of small interfering RNAs (siRNA) as recent therapeutic targets for gene-silencing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.25

Influence of pH gradients on the transbilayer transport of drugs, lipids, peptides and metal ions into large unilamellar vesicles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.25

Formation of transition metal-doxorubicin complexes inside liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.25

An evaluation of transmembrane ion gradient-mediated encapsulation of topotecan within liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.25

Optimization and characterization of a sphingomyelin/cholesterol liposome formulation of vinorelbine with promising antitumor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.25

Pulmonary delivery of insulin by liposomal carriers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.25

Pegylated protein encapsulated multivesicular liposomes: a novel approach for sustained release of interferon alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.25

Membrane models with phospholipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.25

Surrogate cells or Trojan horses. The discovery of liposomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.25

Vesicles of variable sizes produced by a rapid extrusion procedure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.25

Liposomal encapsulated anti-cancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.25

Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.25

The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.25

Mechanism of tumor-targeted delivery of macromolecular drugs, including the EPR effect in solid tumor and clinical overview of the prototype polymeric drug SMANCS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.25

Unusual lipid structures selectively reduce the toxicity of amphotericin B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.25

Accumulation of doxorubicin and other lipophilic amines into large unilamellar vesicles in response to transmembrane pH gradients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.25

Identification of vesicle properties that enhance the antitumour activity of liposomal vincristine against murine L1210 leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.25

Sphingomyelin-cholesterol liposomes significantly enhance the pharmacokinetic and therapeutic properties of vincristine in murine and human tumour models

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.25

Phase II study of SPI-77 (sterically stabilised liposomal cisplatin) in advanced non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.25

A phase II study of STEALTH cisplatin (SPI-77) in patients with advanced non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.25

The accumulation of drugs within large unilamellar vesicles exhibiting a proton gradient: a survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.25

Anomalous solubility behavior of the antibiotic ciprofloxacin encapsulated in liposomes: a 1H-NMR study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.25

Doxorubicin physical state in solution and inside liposomes loaded via a pH gradient

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.25

Therapeutically optimized rates of drug release can be achieved by varying the drug-to-lipid ratio in liposomal vincristine formulations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.25

Ionophore-mediated loading of Ca2+ into large unilamellar vesicles in response to transmembrane pH gradients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.25

Liposome-encapsulated vincristine, vinblastine and vinorelbine: a comparative study of drug loading and retention

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.25

Liposomal vincristine in relapsed non-Hodgkin's lymphomas: early results of an ongoing phase II trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.25

Sphingomyelin/cholesterol liposomal vincristine: a new formulation for an old drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.25

CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.25

Encapsulation of doxorubicin into thermosensitive liposomes via complexation with the transition metal manganese

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.25

Copper-topotecan complexation mediates drug accumulation into liposomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.25

Formation of drug-arylsulfonate complexes inside liposomes: a novel approach to improve drug retention

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.25

Development of a highly active nanoliposomal irinotecan using a novel intraliposomal stabilization strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.25

The formulation of lipid-based nanotechnologies for the delivery of fixed dose anticancer drug combinations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.25

In vitro and in vivo characterization of doxorubicin and vincristine coencapsulated within liposomes through use of transition metal ion complexation and pH gradient loading

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.25

Ratiometric dosing of anticancer drug combinations: controlling drug ratios after systemic administration regulates therapeutic activity in tumor-bearing mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.25

DNA-based therapeutics and DNA delivery systems: a comprehensive review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.25

Stabilized plasmid-lipid particles: construction and characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.25

Stabilized plasmid-lipid particles for systemic gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.25

Stabilized plasmid-lipid particles: a systemic gene therapy vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.25

Stabilized plasmid-lipid particles for regional gene therapy: formulation and transfection properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.25

Spontaneous entrapment of polynucleotides upon electrostatic interaction with ethanol-destabilized cationic liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.25

Efficient encapsulation of antisense oligonucleotides in lipid vesicles using ionizable aminolipids: formation of novel small multilamellar vesicle structures

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.25

High efficiency entrapment of antisense oligonucleotides in liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.25

A scalable, extrusion-free method for efficient liposomal encapsulation of plasmid DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.25

Cationic poly(ethyleneglycol) lipids incorporated into pre-formed vesicles enhance binding and uptake to BHK cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.25

Transfection properties of stabilized plasmid-lipid particles containing cationic PEG lipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.25

Cationic lipid saturation influences intracellular delivery of encapsulated nucleic acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.25

Lipid encapsulation enables the effective systemic delivery of polyplex plasmid DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.25

RNAi therapeutics: principles, prospects and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.25

RNA interference as a novel and powerful tool in immunopharmacological research.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.25

RNA interference: implications for cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.25

RNA interference and innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.25

Postexposure protection of guinea pigs against a lethal ebola virus challenge is conferred by RNA interference

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.25

Bacterial DNA as immune cell activator

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.25

Toll-like receptor 9-mediated recognition of Herpes simplex virus-2 by plasmacytoid dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.25

Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.25

Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.25

A Toll-like receptor recognizes bacterial DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.25

Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.25

Toll-like receptors: cellular signal transducers for exogenous molecular patterns causing immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.25

Sequence-specific potent induction of IFN-alpha by short interfering RNA in plasmacytoid dendritic cells through TLR7

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.25

Induction of inflammatory cytokines and interferon responses by double-stranded and single-stranded siRNAs is sequence-dependent and requires endosomal localization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.25

Design of noninflammatory synthetic siRNA mediating potent gene silencing in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.25

Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.25

CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.25

21 January 2018

Adventures in targeting

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.25

Anti-CD19-targeted liposomal doxorubicin improves the therapeutic efficacy in murine B-cell lymphoma and ameliorates the toxicity of liposomes with varying drug release rates

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.25

Expression and purification of two anti-CD19 single chain Fv fragments for targeting of liposomes to CD19-expressing cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.25

Targeting liposomal chemotherapy via both tumor cell-specific and tumor vasculature-specific ligands potentiates therapeutic efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.25

Ligand-targeted liposomal anticancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.25

Improved therapeutic responses in a xenograft model of human B lymphoma (Namalwa) for liposomal vincristine versus liposomal doxorubicin targeted via anti-CD19 IgG2a or Fab' fragments

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.25

Ligand-targeted liposomes for cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.25

Alkylated derivatives of poly(ethylacrylic acid) can be inserted into preformed liposomes and trigger pH-dependent intracellular delivery of liposomal contents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.25

An enhanced autogene-based dual-promoter cytoplasmic expression system yields increased gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.25

21 January 2018

Identifiers

DOI

10.1517/17425247.5.1.25

1 reference

17 August 2017

1 reference

PubMed ID

18095927